Previous Close | 2.9600 |
Open | 2.9000 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 2.9000 - 2.9600 |
52 Week Range | 1.3800 - 3.5000 |
Volume | |
Avg. Volume | 19,617 |
Market Cap | 16.37M |
Beta (5Y Monthly) | -1.23 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -4.0100 |
Earnings Date | May 15, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 8.00 |
Q3 2024 Aytu Biopharma Inc Earnings Call
Discover how Aytu BioPharma Inc navigates market disruptions and strategic shifts to maintain growth and operational efficiency in Q3 2024.
Q3 2024 ADHD Portfolio net revenue up 49% compared to Q3 2023 Q3 2024 adjusted EBITDA 1 improved by $7.0 million compared to Q3 2023 TTM March 2024 operating income of $7.3 million for the Rx Business TTM March 2024 companywide adjusted EBITDA of ...